MedTrace Logo

Clinical Evaluation of a Specific Enteral Diet for Diabetics

NCT01247714 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2014-12-10

No results posted yet for this study

Summary

The hypothesis of the proposed trials is that the regular intake of a specific diet designed for enteral nutrition of type 2 diabetic patients results into a better nutritional status. Thus, the aim of the study is to scientifically evaluate the healthy effects of the administration of an enteral complete diet for diabetic patients (T-Diet plus Diabet).

Conditions

Interventions

DIETARY_SUPPLEMENT

T-Diet plus Standard

T-Diet plus Standard is a complete balanced protein and energy oral nutrition supplement, indicated for the dietary management of patients with related malnutrition.

DIETARY_SUPPLEMENT

T-Diet plus Diabet NP

T-Diet plus Diabet NP is a complete balanced oral nutrition supplement, indicated for the dietary management of diabetic patients or hyperglycemia related malnutrition.

DIETARY_SUPPLEMENT

Glucerna

GLUCERNA 1.0 CAL is a reduced-carbohydrate, modified-fat, fiber-containing formula clinically shown to blunt blood-glucose response in patients with abnormal glucose tolerance.

DIETARY_SUPPLEMENT

Novasource

Complete high protein diet for diabetic patients and hyperglycemic

Sponsors & Collaborators

  • Vegenat, S.A.

    lead INDUSTRY

Principal Investigators

  • Ángel Gil, PhD · Departament of Biochemistry and Molecular Biology II. University of Granada

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2014-12-31
Completion
2015-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01247714 on ClinicalTrials.gov